Pulmonx is the world leader in interventional pulmonology diagnostics, planning tools, and treatments for obstructive lung disease.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 05/09/19 | $65,000,000 | Venture |
Ally Bridge Group ArrowMark Partners Driehaus Capital Management RTW Investments | undisclosed |
| 05/05/20 | $66,000,000 | Venture |
Adage Capital Management Ally Bridge Group HealthQuest Capital Partner Fund Management Rock Springs Capital | undisclosed |
